BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34176904)

  • 1. Breast Implant-Associated Anaplastic Large Cell Lymphoma With Invasive Chest Wall Masses.
    Coombs DM; Aliotta R; Jagadeesh D; Raymond D; Isakov R
    Ann Plast Surg; 2021 Oct; 87(4):409-414. PubMed ID: 34176904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
    Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
    Lillemoe HA; Miranda RN; Nastoupil LJ; Clemens MW; Hunt KK
    Ann Surg Oncol; 2022 Sep; 29(9):5722-5729. PubMed ID: 35597841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
    Fitzal F; Turner SD; Kenner L
    Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
    Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A
    Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of a Patient With Breast Implant-Associated Anaplastic Large Cell Lymphoma With Local Residual Disease: A Case Report.
    Di Napoli A; Firmani G; Sorotos M; Lopez G; Noccioli N; De Sanctis V; Tafuri A; Santanelli di Pompeo F
    Ann Plast Surg; 2022 Feb; 88(2):152-156. PubMed ID: 34711728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
    Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
    Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
    Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
    Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
    Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
    Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
    K Groth A; Graf R
    Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.
    Longo B; Di Napoli A; Curigliano G; Veronesi P; Pileri S; Martelli M; De Vita R; Felici N; Cirillo P; Bernardi C; D'orsi G; Giacalone M; Storti G; Cervelli V
    Breast; 2022 Dec; 66():332-341. PubMed ID: 36502569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Collins MS; Miranda RN; Medeiros LJ; Silva de Meneses MP; Iyer SP; Butler CE; Liu J; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S. PubMed ID: 30817555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.
    Naga HI; Mellia JA; Basta MN; Morris MP; Christopher AN; Campbell FM; Sommers K; Levinson H; Nelson JA; Fischer JP
    Plast Reconstr Surg; 2022 Oct; 150(4):762-769. PubMed ID: 35862104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach.
    Vorstenbosch J; Ghione P; Plitas G; Horwitz S; Kim M; Cordeiro P; Nelson J; McCarthy C
    Ann Surg Oncol; 2024 Mar; 31(3):2032-2040. PubMed ID: 38102324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients.
    Campanale A; Di Napoli A; Ventimiglia M; Pileri S; Minella D; Curigliano G; Martelli M; De Vita R; Di Giulio P; Montorsi M; Veronesi P; Giordano S; Iachino A; Lispi L
    Eur J Cancer; 2021 May; 148():277-286. PubMed ID: 33765512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
    O'Neill AC; Zhong T; Hofer SOP
    Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.